A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

NCT02275481 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped lack of enrollment

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Arformoterol tartrate inhalation solution
DRUG: Tiotropium

Sponsor

Sumitomo Pharma America, Inc.